ArticleBioengineering (Basel, Switzerland)2025

Radiomics Analysis of Non-Enhancing Lesions After Bevacizumab Administration in Recurrent Glioblastoma.

Takahiro Sanada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.